CancerVAX CEO Ryan Davies Sits Down with Oncology Research Leader
March 20, 2023 03:01 ET
|
CancerVAX, Inc
LEHI, Utah, March 20, 2023 (GLOBE NEWSWIRE) -- CancerVAX, Inc., developer of a breakthrough universal cancer vaccine that will use the body’s immune system to fight cancer, reported that CEO Ryan...
CancerVax Universal Cancer Vaccine Being Developed by UCLA
March 17, 2023 09:46 ET
|
CancerVAX, Inc
LEHI, Utah, March 17, 2023 (GLOBE NEWSWIRE) -- CancerVAX, Inc., developer of a breakthrough universal cancer vaccine that will use the body’s immune system to fight cancer, today announced that its...
CancerVax Files Non-Provisional Patent for Universal Cancer Vaccine
March 16, 2023 16:03 ET
|
CancerVAX, Inc
LEHI, Utah, March 16, 2023 (GLOBE NEWSWIRE) -- CancerVAX, Inc., developer of a breakthrough universal cancer vaccine that will use the body’s immune system to fight cancer, announced that it has...
Ryan Davies Conducts CEO Chat with Leading Biotech IP Expert
January 20, 2023 03:01 ET
|
CancerVAX, Inc
LEHI, Utah, Jan. 20, 2023 (GLOBE NEWSWIRE) -- CancerVAX, Inc., a pre-clinical biotechnology company developing immunotherapy cancer treatments that use the body’s immune system to fight cancer,...
CancerVAX Announces Research Program to Develop Its First Immunotherapy Cancer Treatment
May 26, 2021 11:34 ET
|
CancerVAX, Inc
SANTA BARBARA, Calif., May 26, 2021 (GLOBE NEWSWIRE) -- CancerVAX, Inc., a developer of immunotherapy cancer treatments that use the body’s immune system to fight cancer, today announced that it has...